Risks for mortality and renal replacement therapy in atherosclerotic renovascular disease compared with other causes of chronic kidney disease

Publisher： John Wiley & Sons Inc

E-ISSN： 1440-1797|20|10|688-696

ISSN： 1320-5358

Source： NEPHROLOGY, Vol.20, Iss.10, 2015-10, pp. : 688-696

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evolving Trends in Clinical Presentation of and Renal Replacement Therapy for Chronic Kidney Disease

By  

Nephron Clin Pract, Vol. 111, Iss. 4, 2009-04 ,pp. : c265-c267

Karger

Access to resources Recommend Favorite

The Importance of Associated Extra-Renal Vascular Disease on the Outcome of Patients with Atherosclerotic Renovascular Disease

By  

Nephron Clin Pract, Vol. 93, Iss. 2, 2004-11 ,pp. : c51-c57

Karger

Access to resources Recommend Favorite

The Effects of Statins on the Progression of Atherosclerotic Renovascular Disease

By  

Nephron Clin Pract, Vol. 107, Iss. 2, 2007-08 ,pp. : c35-c42

Karger

Access to resources Recommend Favorite

Geriatric Assessment for Therapeutic Decision-Making Regarding Renal Replacement in Elderly Patients with Advanced Chronic Kidney Disease

By  

Nephron Clin Pract, Vol. 128, Iss. 1-2, 2014-11 ,pp. : 73-78

Karger

Access to resources Recommend Favorite

Erythropoiesis-stimulating protein therapy and the decline of renal function: a retrospective analysis of patients with chronic kidney disease

By Dean Bonnie B.   Dylan Michelle   Gano Anacleto   Knight Kevin   Ofman Joshua J.   Levine Barton S.  

Current Medical Research and Opinion, Vol. 21, Iss. 7, 2005-07 ,pp. : 981-988

Informa Healthcare

Access to resources Recommend Favorite